Blog

Certain aspects of the male factor in infertility remain contentious among specialists and require further research, according to experts. To explore these issues, the Andrology and Men’s Health Unit within the Reproductive Medicine Department at Dexeus Mujer organised an Interdisciplinary Workshop on Male Infertility for health professionals this month.

Despite the theoretical benefit of a euploid embryo screened for aneuploidy by preimplantation genetic testing (PGT-A), the impact of PGT-A on first-trimester aneuploidy screening has not been accurately assessed.

Ovarian stimulation in both the follicular and luteal phases of the same cycle is an innovative strategy to retrieve more oocytes in a shorter time frame. This approach is therefore particularly attractive for patients with a poor ovarian response.

The team of clinicians and scientists from Dexeus Fertility, the Department of Reproductive Medicine of Dexeus University Hospital in Barcelona (Spain), attended the annual Congress of the European Society of Human Reproduction and Embryology (ESHRE), which was held in Amsterdam from 7 to 10 July.

A group of researchers from Dexeus Mujer have carried out a prospective study to assess whether ovarian stimulation primed with oral micronized progesterone, compared to a GnRH antagonist protocol, can affect the yield of euploid blastocysts.

Embryologist Gemma Arroyo, coordinator of the Embryology Group of ESHRE and one of the directors of the IVF laboratories at Dexeus Mujer, was part of the working group that developed this guideline aimed at both patients and professionals.